Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1998
08/13/1998WO1998034622A1 Methods for the administration of amifostine
08/13/1998WO1998034621A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency
08/13/1998WO1998034615A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998WO1998034614A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
08/13/1998WO1998034613A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
08/13/1998WO1998034611A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
08/13/1998WO1998034602A2 Mediation of cytokines by melanin
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998025965A3 Peptides and compounds that bind to the thrombopoietin receptor
08/13/1998WO1998022501A3 Secreted proteins and polynucleotides encoding them
08/13/1998WO1998018917A3 RIBOFLAVIN MUTANTS AS VACCINES AGAINST $i(ACTINOBACILLUS PLEUROPNEUMONIAE)
08/13/1998WO1998011206A3 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
08/13/1998DE19705229A1 Mittel zur hormonalen Kontrazeption Means for hormonal contraception
08/13/1998CA2625727A1 Methods for the administration of amifostine
08/13/1998CA2281792A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
08/13/1998CA2280945A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998CA2280507A1 Substance and method for reduction of lipids and cholesterol
08/13/1998CA2280287A1 Dendritic cell-derived growth factor
08/13/1998CA2280231A1 Member of the tnf family useful for treatment and diagnosis of disease
08/13/1998CA2280195A1 Synthetic hiv gag genes
08/13/1998CA2280190A1 Il-2 gene expression and delivery systems and uses
08/13/1998CA2280140A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
08/13/1998CA2280048A1 Il-8 receptor antagonists
08/13/1998CA2280033A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency
08/13/1998CA2279995A1 Peptide mimetics of the cytokine receptor gamma chain
08/13/1998CA2279946A1 Mediation of cytokines by melanin
08/13/1998CA2279927A1 Fibrinogen receptor antagonist prodrugs
08/13/1998CA2279868A1 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
08/13/1998CA2279863A1 N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
08/13/1998CA2279834A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms
08/13/1998CA2279575A1 Human sdf-5 protein and compositions
08/13/1998CA2279531A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998CA2279231A1 Activity dependent neurotrophic factor iii (adnf iii)
08/13/1998CA2277544A1 Identification of inhibitors of protein tyrosine kinase 2
08/13/1998CA2251999A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/12/1998EP0857787A2 Histidine kinase from Staphylococcus aureaus
08/12/1998EP0857786A1 RNA dependent amidotransferase B from Staphylococcus Aureus
08/12/1998EP0857785A1 RNA dependent amidotransferase C from Staphylococcus Aureus
08/12/1998EP0857487A2 Combinations for prophylaxsis and/or treatment of benign prostatic hyperplasia containing a 17 beta-hydroxy steroid dehydrogenase (17bHSD) inhibitor and at least one further active ingredient
08/12/1998EP0857485A2 Use of acemannan for the treatment of multiple sclerosis and for the correction of malabsorption
08/12/1998EP0857483A1 Substituted aminopyridines in the treatment of glucose metabolism disorders
08/12/1998EP0857428A2 Dietetic soy based products and method for production thereof
08/12/1998EP0857174A1 Urokinase plasminogen activator fragments
08/12/1998EP0857171A2 Imidazole derivatives and the use thereof as nitrogen monoxide synthase inhibitors
08/12/1998EP0751947B1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
08/12/1998EP0741687B1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/12/1998EP0696275B1 Vitamin d amide derivatives
08/12/1998EP0689538B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
08/12/1998EP0629211B1 4-oxo-2-thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
08/12/1998EP0625903B1 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
08/12/1998EP0596891B1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and their use
08/12/1998CN1190438A Chimeric proteins for use in transport of selected substance into cells
08/12/1998CN1190437A 骨刺激因子 Bone-stimulating factor
08/12/1998CN1190402A Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
08/12/1998CN1190401A C-4' modified adenosine kinase inhibitor
08/12/1998CN1190395A Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-£(aminoiminomethyl) phenylalkyl|-azaheterocyclylamide compounds
08/12/1998CN1190393A Diaryldiamine derivatives and their use as delta opioid (ANT)-agonists
08/12/1998CN1190391A Tricyclic benzazepine vasopressin antagonists
08/12/1998CN1190389A Farnesyl transferase inhibitors, its preparation and medicine composition thereof
08/12/1998CN1190348A Method for increasing hematopoietic cell
08/12/1998CN1190096A Compounds analogous to thalidomide from class comprising piperidine-2,6-diones
08/12/1998CN1039491C Tetrahydro-carbazole compound and its preparation and application
08/11/1998US5792882 5-lipoxygenase inhibitors, antiallergens, antiinflammatory agents
08/11/1998US5792849 Polypeptides useful for the stimulation of glial cell (particularly, schwann cell) mitogenesis and treating glial cell tumors
08/11/1998US5792834 Polyethylene-protein conjugates
08/11/1998US5792833 Binds to human papilloma virus
08/11/1998US5792797 Pharmaceutical compounds
08/11/1998US5792789 Acids and esters of diosmetin
08/11/1998US5792788 Substituted thiophenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
08/11/1998US5792786 Sustained and prolonged wound healing agents
08/11/1998US5792784 A pseudo-dipeptide product which is histamine or methyl-substituted histamine coupled with a amino acid; used in therapeutical, cosmetological applications and treats vision defect
08/11/1998US5792783 Capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
08/11/1998US5792772 Enatiomerically pure hydroxylated xanthine compounds
08/11/1998US5792770 Administering as sedative, tranquilizer, anxiolytic agent
08/11/1998US5792763 Serotonin 5-HT1F agonists
08/11/1998US5792762 Dihydrobenzofluorene compounds, intermediates, compositions and methods
08/11/1998US5792759 Steroids, useful for treatement of heart failure and hypertension
08/11/1998US5792745 Use of peptides for altering bone resorption
08/11/1998US5792639 Paraoxonase polypeptides and use therefor
08/11/1998US5792635 Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
08/11/1998US5792626 Human interferon-inducible protein
08/11/1998US5792461 Citrus peel extract as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitor
08/11/1998CA2064160C Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
08/07/1998CA2222987A1 Novel compounds
08/07/1998CA2222978A1 Novel compounds
08/07/1998CA2222961A1 Novel compounds
08/07/1998CA2222957A1 Novel histidine kinase
08/06/1998WO1998034121A2 Isolated p27 protein and methods for its production and use
08/06/1998WO1998033919A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998WO1998033890A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998WO1998033802A1 Quinazolinone compounds
08/06/1998WO1998033798A2 Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
08/06/1998WO1998033795A1 Nanomolar, non-peptide inhibitors of cathepsin d
08/06/1998WO1998033791A1 Dihydropyrimidone derivatives as npy antagonists
08/06/1998WO1998033788A1 Matrix metalloproteinase inhibitors
08/06/1998WO1998033784A1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
08/06/1998WO1998033782A1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
08/06/1998WO1998033780A1 Endothelin antagonists: n-[[2'-[ [(4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide and salts thereof
08/06/1998WO1998033769A1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii
08/06/1998WO1998033768A1 Arylsulfonylamino hydroxamic acid derivatives
1 ... 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 ... 1564